AMARA

Possible AIDS Treatment Shows Promise in Monkeys

... and then these drugs don't work after some time," amara said. In the new study, amara and colleagues injected nine monkeys with an antib...thinks, 'You are not my enemy. You're my friend,'" amara said. But when the signal is blocked, the killer i...

Wild Child's 'Quit Nits' Offers a Safe, Natural Alternative to Current Toxic Head Lice Products

...od of intensive research, Preston developed a prototype of a product (subsequently called "Quit Nits") which used entirely natural plant oils (Quassia amara -- a shrub or small tree of which extracts of the bark contain quassinoids used as insecticides and Eucalyptus globulus -- an evergreen tree, one of t...

AMARA in Medical Technology

GeoVax Reports Progress on Its AIDS Vaccine Technology

...munodeficiency virus (SIV) infected non-human primates with the SIV prototype for the GeoVax AIDS vaccine. In this small pilot study, conducted by Dr. amara at Emory University, two non-human primates were infected with SIV. At 12 weeks post SIV infection, conventional anti-viral drug therapy was given to ...

AMARA in Biological Technology

Performance of the AMARA HitHunter Chemiluminescence Kinase Assay with the LEADseeker Multimodality Imaging System

Key words: AMARA • kinase assay • LEADseeker • chemiluminescence It is predicted that at least 500 kinase and phosphatase enzymes exist, their activities having wide-ranging regulatory responses. Many kinases are part of a signaling cascade ...

GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results

... (SIV) infected non-human primates with the SIV prototype of GeoVax's AIDS vaccine. In this small pilot study, conducted by Dr. Rama amara at Emory University, two non-human primates were infected with SIV. Data from the study revealed outstanding results with the vaccin...

GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update

... our therapeutic vaccine trial in the planning stage. Based on highly promising results in preclinical non-human primate studies conducted by Dr. Rama amara at Emory University, we are eager to launch a therapeutic Phase 1/2 human clinical trial in individuals already infected with HIV to investigate the u...

GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update

... virus (SIV) infected non-human primates with the SIV prototype of GeoVax's AIDS vaccine. In this small pilot study, conducted by Dr. Rama amara at Emory University, two non-human primates were infected with SIV. At 12 weeks post SIV infection, conventional anti-viral drug therapy w...